Document is current
Any future updates will be listed below
-
Authors
Wirth, Wolfgang https://orcid.org/0000-0002-2297-8283
Ladel, Christoph
Maschek, Susanne
Wisser, Anna
Eckstein, Felix
Roemer, Frank
-
Funding
Funding for this research was provided by:
Paracelsus Medical University
- License Information
-
More Information
Article History
Received: 29 August 2022
Revised: 29 October 2022
Accepted: 31 October 2022
First Online: 15 November 2022
Declarations
:
: Wolfgang Wirth: employee and shareholder of Chondrometrics GmbH. Susanne Maschek: employee and shareholder of Chondrometrics GmbH. Anna Wisser: employee of Chondrometrics GmbH. Felix Eckstein: CEO and shareholder of Chondrometrics GmbH and received personal fees from AbbVie, Galapagos NV, HealthLink, ICM, IRIS, Kolon TissueGene, Merck KGaA, Novartis, Roche and Samumed and grants from Foundation for the NIH, University of California, San Francisco, NIH/National Heart, Lung, and Blood Institute, Bioclinica, Galapagos NV, Novartis, TissueGene, Erlangen University Hospital, University of Sydney, CALIBR, University of Basel, University of Western Ontario, Stanford University, ICM Co., Ltd., UMC Utrecht, Federal Ministry of Education and Research, Germany. Christoph Ladel received personal fees from LinkHealth Wengzhou, ReumaNederland Amsterdam, UMC Utrecht, Charité Hospital Berlin. Frank Roemer: shareholder of Boston Imaging Core Lab. (BICL), LLC. He is consultant to Calibr and Grünenthal.
